News Release

Notice of land acquisition by Beijing Continent Pharmaceutical Co., Ltd.

• Chinese Journal of Tuberculosis and Respiratory Diseases recommended the use of Pirfenidone as an anti-fibrosis therapy for COVID-19 patients in China
• Selected 140th in the ranking of Financial Times High-Growth Companies Asia-Pacific 2020